Gefitinib for refractory advanced non-small-cell lung cancer

Lancet. 2006 Jan 28;367(9507):300. doi: 10.1016/S0140-6736(06)68064-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma, Bronchiolo-Alveolar / drug therapy*
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Erlotinib Hydrochloride
  • Female
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Protein Kinase Inhibitors / therapeutic use*
  • Quinazolines / therapeutic use*
  • Smoking / adverse effects*

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Quinazolines
  • Erlotinib Hydrochloride
  • Gefitinib